DrugPatentWatch Database Preview
Profile for Canada Patent: 2454027
US Patent Family Members and Approved Drugs for Canada Patent: 2454027
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Aug 31, 2021 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
➤ Sign Up | Aug 31, 2021 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
➤ Sign Up | Aug 31, 2021 | Astrazeneca Ab | BYDUREON BCISE | exenatide |
➤ Sign Up | Oct 9, 2022 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |